Richard C. Malabre
Senior VP & Chief Accounting OfficerMr. Richard C. Malabre serves as Chief Accounting Officer of Akebia Therapeutics, Inc. since January 8, 2024 and serves as its Senior Vice President. Mr. Malabre also served as a Senior Advisor to Ultivue, Inc. and as an independent financial consultant from September 2023 to December 2023. He served as Chief Financial Officer and Treasurer at Ultivue, Inc since March 2021 until September 2023. Mr. Malabre is an experienced financial manager with experience in finance, accounting, internal audit, financial planning and treasury roles. He served as the Vice President and Corporate Controller of Oxford Immunotec USA, Inc., formerly Oxford Immunotec, Inc., a medical diagnostic company, from 2012 to March 2021. He was most recently the Vice President & Controller at Oxford Immunotec Global PLC where he was responsible for the global accounting, finance and treasury functions during their initial public offering, three acquisitions, a divestiture and sale of the company. Prior to Oxford Immunotec, he held Controller and other senior financial roles at several Medical Device and High Technology firms including Salient Surgical Technologies, Inc., Neurometrix, Inc. and Teradyne, Inc. Mr. Malabre served in various positions at Salient Surgical Technologies, Inc., Medtronic, Inc., NueroMetrix, Inc., Charles River Associates, Enterasys Networks, Inc. and Teradyne, Inc. Mr. Malabre began his financial career at Coopers & Lybrand and is a United States Navy Supply Corps veteran. He earned his BA in Economics from Trinity College, Hartford CT and his Master of Science in Management from MIT’s Sloan School of Management. He is a licensed Certified Public Accountant.
Positions
- Company NameAkebia Therapeutics, Inc.Stock CodeAKBAPositionSenior VP & Chief Accounting OfficerColleagues
- JPJohn P. ButlerCEO, President & Director
- AAAdrian AdamsIndependent Chairperson
- EJErik John OstrowskiChief Business Officer, Senior VP, CFO & Treasurer
- SKSteven Keith BurkeSenior VP and Chief Research & Development Officer
- JMJustin McCueSenior VP & Chief Technology Officer
- CSCynthia SmithIndependent Director
- MWMichael W. RogersIndependent Director
- RERonald E. FriesonIndependent Director
